essence study semaglutide Focus on 2.4 mg/week for the Treatment of Metabolic Dysfunction‐Associated Steatohepatitis - Petta - 2025 - Liver International Phase 3 ESSENCE trial: Semaglutide

GLP-1 agonists may offer stronger weight loss and blood sugar control benefits compared to metformin, but both are effective depending on individual needs

Many notice improved focus and mental sharpness within the first week of treatment

Bialy M, Sachs BD

Theyre only eating when theyre hungry, and theyre stopping when theyre full." Jastreboff agreed that while obesity is "not an addiction," the "food noise," or impulse to eat, uses the same pathways in the brain

Regulation of intestinal permeability: The role of proteases

In many cases, a provider may consider changing the route or protocol if clinically appropriate